Arbutus Biopharma Corp | Market Exclusive

Home Tags Arbutus Biopharma Corp

Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Neutral by Chardan Capital

ME Staff - October 4, 2019 0

Arbutus Biopharma Corp (NASDAQ:ABUS) had its Buy rating reiterated by Chardan...

ME Staff - July 16, 2019 0

Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Buy by B. Riley...

ME Staff - October 16, 2018 0

Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Neutral by Wedbush with...

ME Staff - October 15, 2018 0

Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Hold by Wedbush with...

ME Staff - October 15, 2018 0

Arbutus Biopharma Corp (NASDAQ:ABUS) price target lowered to $6.50 by Chardan...

ME Staff - October 12, 2018 0

Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Underperform by Wedbush

ME Staff - October 9, 2018 0

Arbutus Biopharma Corp (NASDAQ:ABUS) price target raised to $11.50 by B....

ME Staff - August 13, 2018 0

Arbutus Biopharma Corp (NASDAQ:ABUS) had its Outperform rating reiterated by Chardan...

ME Staff - July 16, 2018 0

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

December 9, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 24, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Arbutus Biopharma Corp

Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Neutral by Chardan Capital

Arbutus Biopharma Corp (NASDAQ:ABUS) had its Buy rating reiterated by Chardan...

Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Buy by B. Riley...

Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Neutral by Wedbush with...

Arbutus Biopharma Corp (NASDAQ:ABUS) gets upgraded to Hold by Wedbush with...

Arbutus Biopharma Corp (NASDAQ:ABUS) price target lowered to $6.50 by Chardan...

Arbutus Biopharma Corp (NASDAQ:ABUS) gets downgraded to Underperform by Wedbush

Arbutus Biopharma Corp (NASDAQ:ABUS) price target raised to $11.50 by B....

Arbutus Biopharma Corp (NASDAQ:ABUS) had its Outperform rating reiterated by Chardan...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY